Merck & Co., Inc.
MRK
#40
Rank
$377.724 B
Marketcap
United States
Country
$153.10
Share price
17.39%
Change (1 day)
77.74%
Change (1 year)
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands.…
Key Metrics
Trailing P/E
117.72
Forward P/E
15.41
EPS (TTM)
$1.25
Forward EPS
$9.55
Price / Book
8.66
EV / EBITDA
14.2x
Beta
0.23
Dividend Yield
2.35%
Return on Equity
6.96%
Return on Assets
11.87%
Debt / Equity
128.41
Current Ratio
1.32
Gross Margin
75.90%
Operating Margin
-0.24%
Net Profit Margin
4.77%
Free Cash Flow
$15.172B
Charts
Price history and financial performance over time.
Price & Market Cap
Aug 19 – Sep 16
-4.79%
Source: Yahoo Finance daily closes. Market cap uses the closest quarterly shares-outstanding filing for each date.
Revenue & Net Income
Annual · USD
RevenueNet Income
Latest Revenue$65.011B
Latest Net Income$18.254B
Reporting periods4
Source: Yahoo Finance annual income statements. Year is the fiscal-year end. Most recent period may be trailing-twelve-month (TTM) until the next 10-K is filed.
Compare Merck & Co., Inc. with competitors
Side-by-side market cap, revenue, and financial comparison.
Latest News
Latest News
MRK
No recent news available. Set FINNHUB_API_KEY to enable news.
